New Ray Medicine International Holding Limited (HKG:6108)

HKG:6108 Revenue

New Ray Medicine International Holding had revenue of 44.70M HKD in the half year ending June 30, 2025, with 44.12% growth. This brings the company's revenue in the last twelve months to 121.93M, up 240.05% year-over-year. In the year 2024, New Ray Medicine International Holding had annual revenue of 93.95M with 87.31% growth.

• Revenue (ttm): 121.93M
• Revenue Growth: +240.05%
• P/S Ratio: 0.39
• Revenue / Employee: 4.06M
• Employees: 30
• Market Cap: 47.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	93.95M	43.79M	87.31%
Dec 31, 2023	50.15M	-39.62M	-44.13%
Dec 31, 2022	89.77M	-245.61M	-73.23%
Dec 31, 2021	335.38M	202.17M	151.76%
Dec 31, 2020	133.21M	14.58M	12.29%